HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M.
Blood. 2021 Jul 22;138(3):273-282. doi: 10.1182/blood.2021011281.
Upfront Matched Unrelated Donor Transplantation in Aplastic Anemia.
Clesham K, Dowse R, Samarasinghe S.
Hematol Oncol Clin North Am. 2018 Aug;32(4):619-628. doi: 10.1016/j.hoc.2018.03.004. Epub 2018 May 28.
Matched unrelated donor transplants-State of the art in the 21st century.
Altaf SY, Apperley JF, Olavarria E.
Semin Hematol. 2016 Oct;53(4):221-229. doi: 10.1053/j.seminhematol.2016.07.002. Epub 2016 Jul 25.
Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond.
Gooptu M, Bolaños-Meade J, Koreth J.
Blood Rev. 2023 Nov;62:101053. doi: 10.1016/j.blre.2023.101053. Epub 2023 Feb 3.
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A.
Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028. Epub 2022 Dec 25.
Novel approaches to acute graft-versus-host disease prevention.
Watkins B, Qayed M.
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):155-163. doi: 10.1182/hematology.2023000426.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Marcoux C, Marin D, Ramdial J, AlAtrash G, Alousi AM, Oran B, Kebriaei P, Popat UR, Rezvani K, Champlin RE, Shpall EJ, Mehta RS.
Am J Hematol. 2023 May;98(5):712-719. doi: 10.1002/ajh.26870. Epub 2023 Feb 13.
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.
Mehta RS, Ramdial J, Marin D, Alousi A, Kanakry CG, Champlin RE, Rezvani K, Shpall EJ, Page K, Gadalla SM, Kebriaei P, Weisdorf D.
Transplant Cell Ther. 2023 Jun;29(6):377.e1-377.e7. doi: 10.1016/j.jtct.2023.03.028. Epub 2023 Mar 28.
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.
Grunwald MR, Zhang MJ, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, Mussetti A, Nakamura R, Nishihori T, Saber W, Solh M, Weisdorf DJ, Eapen M.
Blood Adv. 2021 Feb 23;5(4):975-983. doi: 10.1182/bloodadvances.2020003654.
Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation.
Williams L, Cirrone F, Cole K, Abdul-Hay M, Luznik L, Al-Homsi AS.
Front Immunol. 2020 Apr 9;11:636. doi: 10.3389/fimmu.2020.00636. eCollection 2020.
